Short-term topical treatment of wlvovaginal candidiasis with the combination of 5-fluorocytosine and candicidin

References

• Block E. R., Bennet J. E. The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis. Proc. Soc. Exp. Biol. Med. 1973; 142: 476–4801. Block E. R., Bennet J. E. The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis. Proc. Soc. Exp. Biol. Med. 1973; 142: 476–480
   PubMed Web of Science ®Google Scholar
• Brunner J., Engeler V. 5-Fluor-Ocytosin in der Behandlung von Genitalmykosen. Praxis 1974; 63: 1450–14542. Brunner J., Engeler V. 5-Fluor-Ocytosin in der Behandlung von Genitalmykosen. Praxis 1974; 63: 1450–1454
   PubMed Web of Science ®Google Scholar
• Culbertson, Clayton. Monistat: a new fungicide for treatment of vulvovaghal candidiasis. Am. J. Obstet. Gynecol. 1974; 120: 973–9763. Culbertson, Clayton. Monistat: a new fungicide for treatment of vulvovaghal candidiasis. Am. J. Obstet. Gynecol. 1974; 120: 973–976
   PubMed Web of Science ®Google Scholar
• Davis J. E., Frudenfeld J. H., Goddard J. I. Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis. Obstet. Gynecol. 1974; 44: 403–4064. Davis J. E., Frudenfeld J. H., Goddard J. I. Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis. Obstet. Gynecol. 1974; 44: 403–406
   PubMed Web of Science ®Google Scholar
• Diddle A. W., Gardner W. H., Williamson P. J., et al. Oral contraceptive medication and vulvovaginal candidiasis. Obstet. Gynecol. 1969; 34: 373–3775. Diddle A. W., Gardner W. H., Williamson P. J., et al. Oral contraceptive medication and vulvovaginal candidiasis. Obstet. Gynecol. 1969; 34: 373–377
   PubMed Web of Science ®Google Scholar
• Fernex M. Klinische Erfahrung mit 5-Fluorocytosine (5-FC) in der Behandlung von systemischen Mykosen: Cryptococcosis, Candidiasis, Chromoblastomycosis und Aspergillosis. Mykosen. 1979, In press6. Fernex M. Klinische Erfahrung mit 5-Fluorocytosine (5-FC) in der Behandlung von systemischen Mykosen: Cryptococcosis, Candidiasis, Chromoblastomycosis und Aspergillosis. Mykosen. 1979, In press
   Google Scholar
• Fox J. L. Candicidin, a new antifungal antibiotic: first clinical report. Antibiotic Med. 1955; 1: 349–3507. Fox J. L. Candicidin, a new antifungal antibiotic: first clinical report. Antibiotic Med. 1955; 1: 349–350
   Google Scholar
• Frerich W., Gad A. The frequency of Candida infections in pregnancy and their treatment with clotrimazole. Curr. Med. Res. Opin. 1977; 4: 640–6448. Frerich W., Gad A. The frequency of Candida infections in pregnancy and their treatment with clotrimazole. Curr. Med. Res. Opin. 1977; 4: 640–644
   PubMed Web of Science ®Google Scholar
• Gardner H. L., Kaufman R. H. Benign Diseases of the Vulva and Vagina. Mosby, St Louis 1969; 149–1679. Gardner H. L., Kaufman R. H. Benign Diseases of the Vulva and Vagina. MosbySt Louis 1969; 149–167
   Google Scholar
• Giorlando S. W., Torres J. F., Muscillo G. New antifungal antibiotic preparation, clinical dose study. Am. J. Obstet. Gynecol. 1964; 90: 370–37310. Giorlando S. W., Torres J. F., Muscillo G. New antifungal antibiotic preparation, clinical dose study. Am. J. Obstet. Gynecol. 1964; 90: 370–373
   PubMed Web of Science ®Google Scholar
• Grigoriu A., Grigoriu D. The use of 5-fluorocytosine (Ancotil) for the treatment of cutaneous candidiasis (clinical and in vitro studies). Paper (Abst. A.431) presented at the 8th International Congress on Chemotherapy. Athens Oct. 14–21, 1973; 197311. Grigoriu A., Grigoriu D. The use of 5-fluorocytosine (Ancotil) for the treatment of cutaneous candidiasis (clinical and in vitro studies). Paper (Abst. A.431) presented at the 8th International Congress on Chemotherapy. Athens Oct. 14–21, 1973; 1973
   Google Scholar
• Holt R. J. Treatment of vulval candidiasis with 5-fluorocytosine. Br. Med. J. 1974; 4: 52312. Holt R. J. Treatment of vulval candidiasis with 5-fluorocytosine. Br. Med. J. 1974; 4: 523
   Google Scholar
• Jeffcoate N. Principles of Gynaecology. Butterworth, Edinburgh 1975; 312–31313. Jeffcoate N. Principles of Gynaecology. ButterworthEdinburgh 1975; 312–313
   Google Scholar
• Lang W. R., Stella J. G., Benchakan V. Nystatin vaginal tablets in the treatment of candidal vulvovaginitis. Obstet. Gynecol. 1956; 8: 364–36714. Lang W. R., Stella J. G., Benchakan V. Nystatin vaginal tablets in the treatment of candidal vulvovaginitis. Obstet. Gynecol. 1956; 8: 364–367
   PubMed Web of Science ®Google Scholar
• Lapan B. Is the “pill” a cause of vaginal candidiasis? Culture study. N.Y. Stare J. Med. 1970; 70: 949–95115. Lapan B. Is the “pill” a cause of vaginal candidiasis? Culture study. N.Y. Stare J. Med. 1970; 70: 949–951
   PubMedGoogle Scholar
• Perl G., Guttmacher A. F., Jakubowicz H. Vaginal candidiasis: new method of diagnosis and treatment. Obstet. Gynecol. 1955; 5: 640–64816. Perl G., Guttmacher A. F., Jakubowicz H. Vaginal candidiasis: new method of diagnosis and treatment. Obstet. Gynecol. 1955; 5: 640–648
   PubMed Web of Science ®Google Scholar
• Polak A. Synergism between 5-fluorocytosine and polyene antibiotics. Path. Microbiol., (Basel) 1975; 42: 234–23517. Polak A. Synergism between 5-fluorocytosine and polyene antibiotics. Path. Microbiol., (Basel) 1975; 42: 234–235
   PubMedGoogle Scholar
• Polak A. Synergism of polyene antibiotics with 5-fluorocytosine. Chemotherapy 1978; 24: 2–1618. Polak A. Synergism of polyene antibiotics with 5-fluorocytosine. Chemotherapy 1978; 24: 2–16
   PubMed Web of Science ®Google Scholar
• Polak A., Scholer H. J. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans as influenced by pyrimidines and purines. II. Studies on distribution and incorporation. Pathol. Microbiol. (Basel) 1973; 39: 334–34719. Polak A., Scholer H. J. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans as influenced by pyrimidines and purines. II. Studies on distribution and incorporation. Pathol. Microbiol. (Basel) 1973; 39: 334–347
   PubMedGoogle Scholar
• Roberts C. L., Sullivan J. J. Moniliasis: the use of candicidin vaginal ointment for treatment. Calif. Med. 1965; 103: 109–11120. Roberts C. L., Sullivan J. J. Moniliasis: the use of candicidin vaginal ointment for treatment. Calif. Med. 1965; 103: 109–111
   PubMedGoogle Scholar
• Schönebeck J. 5-fluorocytosin - a new antimycotic substance. Lükartidningen 1976; 73: 2342–234421. Schönebeck J. 5-fluorocytosin - a new antimycotic substance. Lükartidningen 1976; 73: 2342–2344
   PubMedGoogle Scholar
• Schönebeck J., Segerbrand E. Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine. Br. Med. J. 1973; 4: 337–33822. Schönebeck J., Segerbrand E. Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine. Br. Med. J. 1973; 4: 337–338
   PubMed Web of Science ®Google Scholar
• Spellacy W. N., Zaias N., Buhi W. C., et al. Vaginal yeast growth and contraceptive practices. Obstet. Gynecol. 1971; 38: 343–34923. Spellacy W. N., Zaias N., Buhi W. C., et al. Vaginal yeast growth and contraceptive practices. Obstet. Gynecol. 1971; 38: 343–349
   PubMed Web of Science ®Google Scholar